• 12 results in Exploration of Targeted Anti-tumor Therapy
    Sort by
    Latest
    Open Access
    Original Article
    Small cell lung cancer: circulating tumor cell lines and expression of mediators of angiogenesis and coagulation
    Aim: Coagulation is frequently activated in cancer patients and has been correlated with an unfavorable prognosis. To evaluate whether a putative release of tissue factor (TF) by circulating tumor  [...] Read more.
    Barbara Rath ... Gerhard Hamilton
    Published: April 28, 2023 Explor Target Antitumor Ther. 2023;4:355–365
    DOI: https://doi.org/10.37349/etat.2023.00139
    View:897
    Download:26
    Times Cited: 0
    Open Access
    Review
    Role of artificial intelligence in oncologic emergencies: a narrative review
    Oncologic emergencies are a wide spectrum of oncologic conditions caused directly by malignancies or their treatment. Oncologic emergencies may be classified according to the underlying physiopathol [...] Read more.
    Salvatore Claudio Fanni ... Emanuele Neri
    Published: April 28, 2023 Explor Target Antitumor Ther. 2023;4:344–354
    DOI: https://doi.org/10.37349/etat.2023.00138
    This article belongs to the special issue Artificial Intelligence for Precision Oncology
    View:1210
    Download:37
    Open Access
    Review
    Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy
    Transforming growth factor-β (TGF-β) signaling is an important pathway for promoting the pathogenesis of inflammatory diseases, including cancer. The roles of TGF-β signaling are heterogeneous and versatile in cancer developmen [...] Read more.
    Max Kam-Kwan Chan ... Patrick Ming-Kuen Tang
    Published: April 28, 2023 Explor Target Antitumor Ther. 2023;4:316–343
    DOI: https://doi.org/10.37349/etat.2023.00137
    This article belongs to the special issue Cancer Immunotherapy and Tumor Microenvironment
    View:1337
    Download:50
    Open Access
    Case Report
    Complete response to third-line treatment with trifluridine/tipiracil (TAS-102) in stage IV colon adenocarcinoma
    A clinical case of a 61-year-old female diagnosed with stage IV right colon adenocarcinoma (unresectable liver and multiple lymph node metastases at the time of diagnosis), Kirsten rat sarcoma viral [...] Read more.
    Celia Lara-Morga ... Luis Cabezón-Gutiérrez
    Published: April 27, 2023 Explor Target Antitumor Ther. 2023;4:307–315
    DOI: https://doi.org/10.37349/etat.2023.00136
    This article belongs to the special issue Biomarkers for Personalized and Precise Cancer Diagnosis and Treatment
    View:762
    Download:19
    Times Cited: 0
    Open Access
    Original Article
    Development and validation of an infrared-artificial intelligence software for breast cancer detection
    Aim: In countries where access to mammography equipment and skilled personnel is limited, most breast cancer (BC) cases are detected in locally advanced stages. Infrared breast thermography is reco [...] Read more.
    Enrique Martín-Del-Campo-Mena ... Yessica González-Mejía
    Published: April 27, 2023 Explor Target Antitumor Ther. 2023;4:294–306
    DOI: https://doi.org/10.37349/etat.2023.00135
    This article belongs to the special issue Artificial Intelligence for Precision Oncology
    View:1606
    Download:37
    Times Cited: 0
    Open Access
    Systematic Review
    Anticancer of genus Syzygium: a systematic review
    Aim: One in eight fatalities globally are considered cancer-related. The need for cancer therapy is growing. Natural products continue to play a role in drug development, as up to 50% of authorized [...] Read more.
    Mahmoud Dogara Abdulrahman, Harmand A. Hama
    Published: April 27, 2023 Explor Target Antitumor Ther. 2023;4:273–293
    DOI: https://doi.org/10.37349/etat.2023.00134
    This article belongs to the special issue Plant Extracts as an Infinite Resource for New Anticancer Agents
    View:1232
    Download:34
    Times Cited: 0
    Open Access
    Case Report
    Cystic presentation of primary hepatic neuroendocrine tumour: a case report with a brief review of literature
    Neuroendocrine tumours (NETs) are a rare type of tumours that arise from the neuroendocrine cells which are distributed throughout the body. Of all the gastrointestinal tumours only 1–2% account for NETs. They have an extremely  [...] Read more.
    Mangesh Londhe ... Charusheela Gore
    Published: April 26, 2023 Explor Target Antitumor Ther. 2023;4:266–272
    DOI: https://doi.org/10.37349/etat.2023.00133
    This article belongs to the special issue Precision Medicine for Cholangiocarcinoma
    Open Access
    Review
    Gut microbiota, an emergent target to shape the efficiency of cancer therapy
    It is now well-acknowledged that microbiota has a profound influence on both human health and illness. The gut microbiota has recently come to light as a crucial element that influences cancer throu [...] Read more.
    Soumaya Kouidhi ... Amel Ben Ammar El Gaaied
    Published: April 26, 2023 Explor Target Antitumor Ther. 2023;4:240–265
    DOI: https://doi.org/10.37349/etat.2023.00132
    This article belongs to the special issue Cancer Immunotherapy and Tumor Microenvironment
    View:1379
    Download:39
    Open Access
    Original Article
    A potent bioactive fraction against colon cancer from Plectranthus vettiveroides
    Aim: This study was designed to investigate the anticancer efficacy of the organic leaf extracts of the plant, Plectranthus vettiveroides (P. vettiveroides), and to analyze the molecular mechanism  [...] Read more.
    Faisal M. Athikkavil ... Smitha V. Bava
    Published: April 24, 2023 Explor Target Antitumor Ther. 2023;4:227–239
    DOI: https://doi.org/10.37349/etat.2023.00131
    This article belongs to the special issue Plant Extracts as an Infinite Resource for New Anticancer Agents
    View:1146
    Download:25
    Open Access
    Letter to the Editor
    Clinicopathological relevance of stem cell marker growth and differentiation factor 3 in esophageal squamous cell carcinoma
    Esophageal squamous cell carcinoma (ESCC) is the second leading cause of cancer-related deaths in Iran, often diagnosed in advanced stages with a poor prognosis. Growth and differentiation factor 3  [...] Read more.
    Sara Tahbazzadeh Moghaddam, Mohammad Mahdi Forghanifard
    Published: April 24, 2023 Explor Target Antitumor Ther. 2023;4:217–226
    DOI: https://doi.org/10.37349/etat.2023.00130
    View:642
    Download:16
    Times Cited: 0